At the same time, the effect of SLC31A1 expression level on patient prognosis was evaluated to provide a new perspective for understanding the role of copper death pathway in thyroid papillary carcinoma and explore potential diagnosis and treatment strategies, thereby advancing both our fundamental understanding of PTC biology and the development of targeted treatment strategies. This evidence concerns the gene SLC31A1 and differentiated thyroid carcinoma.